The best Bull and Bear pitches based on recency and number of recommendations.
Transition has been disappointing their long-term believers for years with glacially slow progression of development of Alzheimer's drug scyllo-inositol, also known as ELND005 and AZD-103. Along the way, the two higher dosage groups of a phase II… More
Didn't I bash Transition Therapeutics before? These micro cap biotechs all start looking alike when they have only one or two drugs in the works and a boatload of cash they're burning through. Transition recognized a one-time payment from Elan this… More
Read the most recent pitches from players about TTHI.DL.
Find the members with the highest scoring picks in TTHI.DL.
See what the Wall Street professionals think, according to their public statements and filings.